Login / Signup

[The trial of the efficacy and safety of sequential therapy with Mexidol forte 250 in acute and early recovery stages of hemispheric ischemic stroke].

M A LoskutnikovM A DomashenkoT M VakinI A TrushinaV I KonstantinovO S ProskuryakovaE P Shchukina
Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2020)
Prolonged and sequential therapy with mexidol at the dose 500 mg daily during 14 days (saturation phase) and mexidol forte 250 at the dose of 250 mg three times a day during 60 days (maximum therapeutic effect) provides additional opportunities for a more complete recovery in acute and early recovery stages of hemispheric ischemic stroke (increases quality of life, improves movement and cognitive functions).
Keyphrases
  • liver failure
  • respiratory failure
  • atrial fibrillation
  • aortic dissection
  • clinical trial
  • physical activity
  • study protocol
  • phase iii
  • cell therapy
  • mechanical ventilation